Where Opportunity is Found: Special Research on LendingTree, Bank of America, Actavis, Royal Bank of Canada, and Dycom
NEW YORK, February 26, 2015 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Moments ago, Analysts Review released new research updates concerning several important developing situations including LendingTree (NASDAQ: TREE), Bank of America (NYSE:BAC), Actavis (NYSE:ACT), Royal Bank of Canada (NYSE: RY), and Dycom (NYSE: DY). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
To access our full PDF reports on a complementary basis, please visit the links below.
--
Today's update concerns the following companies:
============
Full PDF Download Links (you may have to copy and paste the following links into your browser):
TREE Research Report: ( http://get.analystsreview.com/pdf/?c=LendingTree&d=26-Feb-2015&s=TREE ),
BAC Research Report: ( http://get.analystsreview.com/pdf/?c=Bank%20of%20America&d=26-Feb-2015&s=BAC ),
ACT Research Report: ( http://get.analystsreview.com/pdf/?c=Actavis&d=26-Feb-2015&s=ACT ),
RY Research Report: ( http://get.analystsreview.com/pdf/?c=Royal%20Bank%20of%20Canada&d=26-Feb-2015&s=RY ),
DY Research Report: ( http://get.analystsreview.com/pdf/?c=Dycom&d=26-Feb-2015&s=DY ).
============
--
Analyst Update: Record Quarterly Performance, FDA Approval, and Litigation Settlement
Reviewed by: Rohit Tuli, CFA®
U.S. stock markets witnessed a mixed trend on Wednesday as the Dow inched further into record territory but the Nasdaq broke its 10-day winning streak. The Dow Jones Industrial Average rose 15.38 points, or 0.08%, to 18224.57. The S&P 500 lost 1.62 points to 2113.86, while the Nasdaq Composite declined 0.98 points, or 0.02%, to 4967.14. Trading was relatively subdued ahead of the release of economic data on Thursday, as investors reviewed the latest corporate earnings news and digested remarks by Fed Chair. European stocks were down as mixed corporate results halted the rally that had propelled FTSE 100 and DAX to record highs. FTSE 100 was down 0.21% to 6935.38. Chinese stocks climbed to a four-week high amid speculation the nation will do more to support economic growth. China's HSBC/Markit Purchasing Managers' Index (PMI) inched up to 50.1 in February. Economists polled by Reuters had forecast a reading of 49.5, little changed from January's final PMI of 49.7. Japan's key Nikkei 225 index fell 0.1% and Australia's benchmark S&P ASX 200 index gained 0.3%.
LendingTree, Inc.'s (LendingTree) stock jumped 6.65% on Wednesday as the operator of leading online loan marketplace reported record fourth quarter 2014 results and increased its outlook for 2015. To read more on the quarterly performance of the Company which reached new records during the quarter, visit our research report on LendingTree.
Shares of Bank of America Corporation (Bank of America) gained 0.67% to $16.49 on Wednesday. In its 10-K filing with SEC, the bank informed that it has agreed to pay $300 million in settlement of a lawsuit brought by group of lenders that helped finance construction of the failed Fontainebleau Resort and Casino project in Las Vegas. Continue reading about Bank of America's settlement on Fontainebleau Resort and Casino project litigation in our recent research report.
Shares of Actavis plc ended Wednesday's trading at $290.40, up 0.45%, on volume of 12.55 million shares following reports that the Company has received U.S. FDA approval for AVYCAZ™ (ceftazidime-avibactam). The Company also announced the pricing of public offerings of ordinary shares and mandatory convertible preferred shares in connection with pending acquisition of allergan. Know more about Actavis' work on AVYCAZ in our recent research report.
Shares of Royal Bank of Canada jumped 4.24% to end Wednesday's session at $62.64 as the largest bank of Canada reported record Q1 fiscal 2015 results led by its capital market segment. Net income for the quarter stood at $2.5 billion or $1.65 per diluted share versus $2.1 billion or $1.38 per diluted share in Q1 FY 2014. To know more about the financial results of the Company, read our report on Royal Bank of Canada.
Second quarter 2015 results of specialty contracting-services provider Dycom Industries Inc. (Dycom ) drove the Company's share prices to a 52 week high of $43.93, before closing at $43.65 on Tuesday. Q2'15 earnings per share surpassed Zacks Consensus Estimate of 10 cents by an astounding 170%. The Company swung to a profit of $9.4 million or $0.27 per diluted common share, compared to a net loss of $3.1 million, or $0.09 loss per common share in the year-ago quarter. Top-line too witnessed a healthy growth. To know more about the robust performance of the Company, please read our research report on Dycom Industries Inc.
--
About Analysts Review
At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.
--
Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article